The Effect of Growth Hormone (GH) on Histomorphometric Indices of Bone Structure and Bone Turnover in GH-Deficient Men

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1818-1822

  Bravenboer, Nathalie ^a   Holzmann, Paulien ^b   De Boer, Hans ^a   Roos, Jan C ^a   Van Der Veen, Eduard A ^a   Lips, Paul ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; BONE; BONE DENSITY; BONE REMODELING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MALE; METABOLISM; OSTEOLYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BONE AND BONES; BONE DENSITY; BONE REMODELING; BONE RESORPTION; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; RECOMBINANT PROTEINS;

EID: 0031156847     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.6.3982     Document Type: Article

References (23)

1. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassanger C, Christiansen C. 1991 The effect of growth hormone (GH) therapy on urinary pyridinolin cross-links in GH deficient adults. Clin Endocrinol (Oxf). 35:471-476.
2. Whitehead HM, Boreham C, McLirath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency; a result of a 13 month placebo controlled cross-over study. Clin Endocrinol (Oxf). 36:45-52.
3. Sartorio A, Conti A, Monzani M, Morabito F, Faglia G. 1993 Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest. 16:893-898.
4. van de Weghe M, Taelman P, Kaufman JM. 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone deficient males. Clin Endocrinol (Oxf). 39:409-415.
5. Beshyah SA, Kyd P, Thomas E, Fairny A, Johnston DG. 1995 The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf). 42:249-254.
6. Degerblad M, Elgindy N, Hall K, Sjöberg HE, Thorén M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
7. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM. 1995 Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol (Oxf). 42:627-633.
8. Bravenboer N, Holzmann P, de Boer H, Blok GJ, Lips P. 1996 Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. Bone 18:551-557.
9. de Boer H, Blok GJ, van Lingen A, Teule GJJ, Lips P, Van der Veen EA. 1994 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 9:1319-1326.
10. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E. 1996 Monitoring of growth hormone replacement therapy in adults, based on measurements of serum markers. J Clin Endocrinol Metab. 81:1371-1377.
11. De Boer H, Blok GJ, Voerman B, de Vries P, Popp-Snijders C, van der Veen E. 1995 The optimal growth hormone replacement dose in adults derived from bioimpedance analysis. J Clin Endocrinol Metab. 80:2069-2076.
12. Meunier PJ. 1983 Histomorphometry of the skeleton. In: Peck WA, ed. Bone and mineral research. Annual 1. Amsterdam: Excerpta Medica; 191-222.
13. Teerlink T, Tavenier P, Netelenbos JC. 1989 Selective determination of hydroxyproline in urine by high performance liquid chromatography using procolumn derivatization. Clin Chim Acta. 183:309-315.
14. Buijs R, Dogterom AA. 1983 An improved method for embedding hard tissue in polymethyl methacrylate. Stain Technology. 58:135-141.
15. Theuns HM, Bekker H, Fokkenrood H, Offerman E. 1993 Methyl-methacrylate embedding of undecalcified rat bone and simultaneous staining for alkaline and tartrate resistant acid phosphatase. Bone. 14:545-550.
16. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987 Bone histomorphometry: standardisation of nomenclature, symbols, and units. J Bone Miner Res. 2:545-610.
17. Grinspoon SK, Baum HBA, Peterson S, Klibansky A. 1995 Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest. 96:900-406.
18. Andreassen TT, Jorgensen PH, Flyvbjerg A, Ørskov H, Oxlund H. 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res. 11:1094-1102.
19. Andreassen TT, Melsen F, Oxlund H. 1996 The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res. 11:1094-1102.
20. Johansson G, Rosén T, Bosaeus I, Sjöström L, Bengtson BA. 1996 Two years of growth hormone (GH) treatment increase bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 81:2865-2873.
21. Ter Maaten JC, De Boer H, Roos JC, Lips P, Van der Veen EA. 1997 Long-term effects of growth hormone treatment on bone density. Endocrinol Metab. [Suppl A]:8.
22. Parfitt AM. 1980 Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab. 4:273-287.
23. Halse J, Melsen F, Mosekilde Le. 1981 Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol (Copenh). 97:18-22.